These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 19447330)

  • 1. [What's new in 2008 in kidney cancer?].
    Phé V; Rouprêt M; Lechevallier E; Patard JJ
    Prog Urol; 2009 May; 19 Suppl 2():S56-64. PubMed ID: 19447330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What's new in the treatment of metastatic kidney cancer?
    Mancuso A; Sternberg CN
    BJU Int; 2005 Jun; 95(9):1171-80. PubMed ID: 15892796
    [No Abstract]   [Full Text] [Related]  

  • 3. [Kidney cancer: news in 2008].
    Patard JJ; Lechevallier E; Descazeaud A
    Prog Urol; 2008 Sep; 18 Suppl 6():S135-40. PubMed ID: 18822264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multimodality treatment paradigms for renal cell carcinoma: surgery versus targeted agents.
    Köpke T; Bierer S; Wülfing C; Tiemann A; Hertle L; Herrmann E
    Expert Rev Anticancer Ther; 2009 Jun; 9(6):763-71. PubMed ID: 19496713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current world literature. Kidney cancer.
    Curr Opin Urol; 2007 Sep; 17(5):376-8. PubMed ID: 17762634
    [No Abstract]   [Full Text] [Related]  

  • 6. Robot assisted partial nephrectomy versus laparoscopic partial nephrectomy for renal tumors: a multi-institutional analysis of perioperative outcomes.
    Benway BM; Bhayani SB; Rogers CG; Dulabon LM; Patel MN; Lipkin M; Wang AJ; Stifelman MD
    J Urol; 2009 Sep; 182(3):866-72. PubMed ID: 19616229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Progress and summary of recent congress: ASCO-GU, EAU, AUA, ASCO about the medical management of locally advanced or metastatic kidney cancer].
    Patard JJ; Escudier B; Paparel P; Neuzillet Y; Long JA; Baumert H; Correas JM; Lang H; Poissonnier L; Rioux-Leclercq N; Soulié M;
    Prog Urol; 2010 Mar; 20 Suppl 1():S11-5. PubMed ID: 20493436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Kidney tumors].
    Méjean A; André M; Doublet JD; Fendler JP; de Fromont M; Hélénon O; Lang H; Négrier S; Patard JJ; Piéchaud T;
    Prog Urol; 2004 Nov; 14(4 Suppl 1):997, 999-1035. PubMed ID: 15779656
    [No Abstract]   [Full Text] [Related]  

  • 9. [On kidney neoplasms].
    Bergmann M; Lipsky H
    Chirurg; 1968 Jan; 39(1):32-6. PubMed ID: 5665283
    [No Abstract]   [Full Text] [Related]  

  • 10. From the guest editors: the dramatic advances in the treatment of metastatic renal cancer that have occurred over the last 3 years, with an eye toward the potential future directions of the field.
    Samlowski WE; Vogelzang NJ
    Cancer J; 2008; 14(5):286-7. PubMed ID: 18836332
    [No Abstract]   [Full Text] [Related]  

  • 11. Status of adjuvant therapy for renal cell cancer.
    Sagalowsky A; Donohue J
    J Indiana State Med Assoc; 1979 Jul; 72(7):521-4. PubMed ID: 383849
    [No Abstract]   [Full Text] [Related]  

  • 12. Advanced renal cell carcinoma: what to do after first line antiangiogenic therapy?
    Soulières D
    Curr Opin Support Palliat Care; 2009 Sep; 3(3):153-6. PubMed ID: 19512932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Everolimus (RAD001): an mTOR inhibitor for the treatment of metastatic renal cell carcinoma.
    Oudard S; Medioni J; Aylllon J; Barrascourt E; Elaidi RT; Balcaceres J; Scotte F
    Expert Rev Anticancer Ther; 2009 Jun; 9(6):705-17. PubMed ID: 19496707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bilateral leiomyosarcoma of the kidney with family history of kidney cancer.
    Kadikoy H; Haque WM; Topkara VK; Frome AI; Hayes TG
    Can J Urol; 2009 Oct; 16(5):4847-9. PubMed ID: 19796464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrasonography in the evaluation of post-nephrectomy renal cancer patients.
    Bernardino ME; Green B; Goldstein HM
    Radiology; 1978 Aug; 128(2):455-8. PubMed ID: 663259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of Wilms tumor: current standard of care.
    Sonn G; Shortliffe LM
    Nat Clin Pract Urol; 2008 Oct; 5(10):551-60. PubMed ID: 18836464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytoreductive nephrectomy in metastatic renal cell carcinoma: the evolving role of surgery in the era of molecular targeted therapy.
    Kwan KG; Kapoor A
    Curr Opin Support Palliat Care; 2009 Sep; 3(3):157-65. PubMed ID: 19528804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metastatic renal cell carcinoma: many treatment options, one patient.
    Rini BI
    J Clin Oncol; 2009 Jul; 27(19):3225-34. PubMed ID: 19470934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Robot-assisted partial nephrectomy: current perspectives and future prospects.
    Gautam G; Benway BM; Bhayani SB; Zorn KC
    Urology; 2009 Oct; 74(4):735-40. PubMed ID: 19616827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in kidney cancer and metastatic disease.
    Kirkali Z; Tuzel E; Mungan MU
    BJU Int; 2001 Nov; 88(8):818-24. PubMed ID: 11736854
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.